SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : analysts and calls -- B of A

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject5/12/2003 10:06:28 AM
From: scaram(o)uche   of 33
 
Friedman, Billings, Ramsey Announces Addition to Healthcare Analyst Team
Monday May 12, 9:20 am ET
Senior Analyst Dr. James F. Reddoch to Oversee Biotechnology Coverage

ARLINGTON, Va., May 12 /PRNewswire-FirstCall/ -- As part of an ongoing development of its healthcare business sector emphasis, Friedman, Billings, Ramsey & Co., Inc., a wholly owned subsidiary of Friedman, Billings, Ramsey Group, Inc. (NYSE: FBR - News), today announced the appointment of Dr. James F. Reddoch, 33, as Senior Vice President and Senior Analyst of Biotechnology Research. He will oversee the firm's coverage of biotechnology companies with particular focus on therapeutics. Reddoch will report to Martin S. Friedman, FBR's Director of Research.

Prior to joining FBR, Reddoch served as a Senior Analyst in the Healthcare Group at Banc of America Securities, New York. Earlier he held the position of Senior Biotechnology Research Associate at CIBC World Markets Corp. Reddoch holds a Ph.D. in Biochemistry and Molecular Genetics from the University of Alabama and completed a postdoctoral fellowship in Therapeutic Radiology at Yale University's School of Medicine.

"Dr. Reddoch's appointment reflects continued progress in and commitment to FBR's building to the breadth and depth of its healthcare franchise," said Martin Friedman. "His academic credentials and Wall Street experience make him eminently qualified to effectively evaluate biotechnology companies for our investors."

Friedman, Billings, Ramsey Group, Inc. provides investment banking*, institutional brokerage*, specialized asset management, and private client services through its operating subsidiaries and invests in mortgage-backed securities and merchant banking opportunities. FBR focuses capital and financial expertise on six industry sectors: financial services, real estate, technology, healthcare, energy and diversified industries. FBR, headquartered in the Washington, D.C. metropolitan area, with offices in Arlington, Va. and Bethesda, Md., also has offices in Atlanta, Boston, Charlotte, Chicago, Cleveland, Dallas, Denver, Irvine, London, New York, Portland, San Francisco, Seattle, and Vienna. FBR has elected REIT status for tax purposes. For more information, see fbr.com .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext